| 摘要 |
Disclosed are compounds of formula (I), formula (II), and formula (III): wherein Ar, R1, A, and X are as defined in the specification. These compounds are antiviral agents and are contemplated for use in the treatment of viral infections, for example, hepatitis C. These compounds are also contemplated for use in treating or preventing cancers. |
| 申请人 |
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;UNIVERSITY OF KANSAS |
发明人 |
LIANG, TSANYANG;HU, ZONGYI;MARUGAN, JUAN JOSE;SOUTHALL, NOEL TERRENCE;HE, SHANSHAN;HU, XIN;XIAO, JINGBO;FERRER, MARC;ZHENG, WEI;FRANKOWSKI, KEVIN J.;SCHOENEN, FRANK J.;LI, KELIN |
